C2N Diagnostics
Saint Louis
About C2N Diagnostics
C2N Diagnostics is a specialty diagnostics company focused on providing laboratory services and products in brain health with innovative technologies. The C2N Diagnostics PrecivityAD Test helps physicians determine the presence of amyloid plaques in the brain, which is crucial for Alzheimer's diagnosis. C2N is known for its high-performance blood biomarkers aimed at early diagnosis and therapeutic discovery related to brain health conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $95.7M
- Last round: Series Unknown (May 2025)
- Website: c2n.com
- Phone: 314-633-1884
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/c2n-diagnostics-79355 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.